Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal

HBV and HCV infections are widespread among the HIV-infected individuals in Nepal. The goals of this study were to investigate the epidemiological profile and risk factors for acquiring HBV and/or HCV coinfection in disadvantaged HIV-positive population groups in Nepal. We conducted a retrospective...

Full description

Bibliographic Details
Main Authors:	Manjula Bhattarai, Jagat Bahadur Baniya, Nirmal Aryal, Bimal Shrestha, Ramanuj Rauniyar, Anurag Adhikari, Pratik Koirala, Pardip Kumar Oli, Ram Deo Pandit, David A. Stein, Birendra Prasad Gupta
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/9241679

Similar Items

Evaluation of Five International HBV Treatment Guidelines: Recommendation for Resource-Limited Developing Countries Based on the National Study in Nepal
by: Sundar Khadka, et al.
Published: (2020-11-01)

HBV and HCV Therapy
by: Massimo Colombo, et al.
Published: (2009-10-01)

HBV And HCV Molecular Evolution
by: Flor H. Pujol
Published: (2007-02-01)

Treatment of HBV–HCV coinfection
by: Rocío Torres Ibarra
Published: (2006-01-01)

Animal models for HCV and HBV studies
by: Isabelle Chemin
Published: (2007-02-01)

Recent Advances in HBV and HCV Immunology
by: Lynn B Dustin, et al.
Published: (2015-09-01)

A case of acute coinfection with HBV and HCV
by: DONG Bing, et al.
Published: (2016-08-01)

HBV and HCV genotypes distribution on the territory of Belarus
by: Gasich EL, et al.
Published: (2012-05-01)

Glomerular diseases associated with HBV and HCV infection
by: Boriana Kiperova
Published: (2014-03-01)

Seroprevalances of HBV, HCV and HIV in Hakkari Province
by: Fikret Tekay
Published: (2006-01-01)

HBV-DNA in hemodialysis patients infected by HCV
by: Arababadi Mohammad, et al.
Published: (2009-01-01)

Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal
by: Ananta Shrestha, et al.
Published: (2017-11-01)

The impact of HBV/HCV coinfection on HBV DNA levels and the severity of liver diseases in HBV-infected patients undergoing hemodialysis
by: ZHU Fusheng
Published: (2013-02-01)

HBV & HCV–Awareness in Acute Abdomen Emergency Cases
by: Hardeep Singh Gill, et al.
Published: (2014-06-01)

THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION
by: Nina S. Nikolova, et al.
Published: (2013-08-01)

Prevalence of HBV and HCV among blood donors in Kosovo
by: Telaku Skender, et al.
Published: (2009-02-01)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
by: Almudena Torres-Cornejo, et al.
Published: (2017-04-01)

HBV/HCV重叠感染的研究进展
by: HE Li
Published: (2014-06-01)

Heme and HO-1 inhibition of HCV, HBV, and HIV
by: Warren N Schmidt, et al.
Published: (2012-10-01)

HBV, HCV and HIV Seroprevalence in Soldiers Tested for Carriership
by: Ozcan Deveci, et al.
Published: (2014-06-01)

HIV, HCV and HBV: A Review of Parallels and Differences
by: Maria C. Leoni, et al.
Published: (2018-09-01)

Pathogenesis of hepatocellular carcinoma induced by HBV and HCV infection
by: WANG Yuejiao, et al.
Published: (2017-07-01)

The Effectiveness and Benefit of pay-for-performance in HBV and HCV patients
by: Hui-Fang Hung, et al.
Published: (2013)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
by: Alicja E. Grzegorzewska, et al.
Published: (2017-01-01)

HBV/HCV co-infection complicated by HBV-associated glomerulonephritis: a report of one case
by: XUE Liang
Published: (2016-07-01)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
by: Cristina Stasi, et al.
Published: (2016-07-01)

N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis
by: Dhan Bahadur Shrestha, et al.
Published: (2021-09-01)

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors
by: J.S.F. Pereira, et al.
Published: (2006-04-01)

Microfilaria persistent foci during post MDA and the risk assessment of resurgence in India
by: Pramod Kumar Mehta, et al.
Published: (2018-07-01)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
by: Monia Puglia, et al.
Published: (2016-07-01)

VEQ IN BIOLOGIA MOLECOLARE (HCV, HIV, HBV): PRIME ESPERIENZE
by: M.G. Colao, et al.
Published: (2007-09-01)

HBV and HCV Seroprevalence in Rheumatology Patients Using Biological Drugs
by: Mehmet Ali Balcı, et al.
Published: (2020-12-01)

Features of combined (hbv/hcv-infection) viral lesion of the liver
by: I V Maev, et al.
Published: (2008-02-01)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
by: Chavhunduka Evans, et al.
Published: (2009-10-01)

Treatment of HBV/HCV co-infected patients in DAA era
by: Wang Cheng, et al.
Published: (2017-06-01)

HBV, HCV co-infection among blood donors in Nigeria
by: Opaleye O, et al.
Published: (2010-01-01)

Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV Infection
by: Wan-Yu Li, et al.
Published: (2010-01-01)

Knowledge of HBV and HCV and individuals' attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan.
by: Hisashi Eguchi, et al.
Published: (2013-01-01)

Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
by: Wenbo Zhu, et al.
Published: (2012-01-01)

Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection
by: Xubo Huang, et al.
Published: (2021-08-01)